The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

The company develops minimally invasive solutions for patients with obstructive sleep apnea ... expand Inspire’s total addressable market by causing more people with obesity to seek treatment ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment ... are other companies offering treatment for OSA, such as ResMed (RMD) and Inspire Medical Systems (INSP).

Zepbound is typically used to treat obesity–but it can also be used to help treat sleep apnea. Dr. Adhinav Singh joined FOX59 ...

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for ...

and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. For additional information about Inspire ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in ...